REDEFINE 1 (Garvey et al., NEJM 2025) is the only Phase 3 trial of an amylin + incretin co-administered combination, pairing cagrilintide 2.4 mg with semaglutide 2.4 mg
Open the film pouch
E.CorteseI.ReichD
So a concern has logically developed as to whether exogenous antioxidant compounds taken concurrently during chemotherapy could reduce the beneficial effect of chemotherapy on malignant cells
The study suggests BPC-157 may help humans as it does animals, but cannot establish efficacy with scientific rigor
[Ingredients] Mixed preparation (yeast extract (Indian product), lecithin, citric acid), pullulan, pectin, enzyme-treated stevia, steviol glycosides, flavoring (lemon flavor), glycerin, amide pectin, polysorbate 80, milk thistle extract powder (American product) ), L-cysteine hydrochloride, nicotinic acid amide, vitamin B6 hydrochloride, vitamin B12 mixed preparation (dextrin, trisodium citrate, citric acid, vitamin B12), vitamin C, dried yeast (contains selenium, made in Canada), elastin (made in France), Gardenia yellow pigment, collagen (made in India), hyaluronic acid (made in Korea)